18 research outputs found
Cost-Effectiveness of Genotypic Antiretroviral Resistance Testing in HIV-Infected Patients with Treatment Failure
BACKGROUND: Genotypic antiretroviral resistance testing (GRT) in HIV infection with drug resistant virus is recommended to optimize antiretroviral therapy, in particular in patients with virological failure. We estimated the clinical effect, cost and cost-effectiveness of using GRT as compared to expert opinion in patients with antiretroviral treatment failure. METHODS: We developed a mathematical model of HIV disease to describe disease progression in HIV-infected patients with treatment failure and compared the incremental impact of GRT versus expert opinion to guide antiretroviral therapy. The analysis was conducted from the health care (discount rate 4%) and societal (discount rate 2%) perspective. Outcome measures included life-expectancy, quality-adjusted life-expectancy, health care costs, productivity costs and cost-effectiveness in US Dollars per quality-adjusted life-year (QALY) gained. Clinical and economic data were extracted from the large Swiss HIV Cohort Study and clinical trials. RESULTS: Patients whose treatment was optimized with GRT versus expert opinion had an increase in discounted life-expectancy and quality-adjusted life-expectancy of three and two weeks, respectively. Health care costs with and without GRT were US 419,000, leading to an incremental cost-effectiveness ratio of US 551,000 and $US 549,000, respectively. When productivity changes were included in the analysis, GRT was cost-saving. CONCLUSIONS: GRT for treatment optimization in HIV-infected patients with treatment failure is a cost-effective use of scarce health care resources and beneficial to the society at large
Empirical use of antibiotics and adjustment of empirical antibiotic therapies in a university hospital: a prospective observational study
BACKGROUND: Several strategies to optimise the use of antibiotics have been developed. Most of these interventions can be classified as educational or restrictive. Restrictive measures are considered to be more effective, but the enforcement of these measures may be difficult and lead to conflicts with prescribers. Any intervention should be aimed at targets with the highest impact on antibiotic prescribing. The aim of the present study was to assess the adequacy of empirical and adjusted antibiotic therapies in a Swiss university hospital where no antibiotic use restrictions are enforced, and to identify risk factors for inadequate treatment and targets for intervention. METHODS: A prospective observational study was performed during 9 months. All patients admitted through the emergency department who received an antibiotic therapy within 24 hours of admission were included. Data on demographic characteristics, diagnoses, comorbidities, systemic inflammatory response syndrome (SIRS) parameters, microbiological tests, and administered antibiotics were collected prospectively. Antibiotic therapy was considered adequate if spectrum, dose, application modus, and duration of therapy were appropriate according to local recommendations or published guidelines. RESULTS: 2943 admitted patients were evaluated. Of these, 572 (19.4%) received antibiotics within 24 hours and 539 (94%) were analysed in detail. Empirical antibiotic therapy was inadequate in 121 patients (22%). Initial therapy was adjusted in 168 patients (31%). This adjusted antibiotic therapy was inadequate in 46 patients (27%). The main reason for inadequacy was the use of antibiotics with unnecessarily broad spectrum (24% of inadequate empirical, and 52% of inadequate adjusted therapies). In 26% of patients with inadequate adjusted therapy, antibiotics used were either ineffective against isolated pathogenic bacteria or antibiotic therapy was continued despite negative results of microbiological investigations. CONCLUSION: The rate of inadequate antibiotic therapies was similar to the rates reported from other institutions despite the absence of a restrictive antibiotic policy. Surprisingly, adjusted antibiotic therapies were more frequently inappropriate than empirical therapies. Interventions aiming at improving antibiotic prescribing should focus on both initial empirical therapy and streamlining and adjustment of therapy once microbiological results become available
Is silence golden? A test of the incorporation of the effects of ill-health on income and leisure in health state valuations
Revisiting the decision rule of cost-effectiveness analysis under certainty and uncertainty
A risk-adjusted approach to comparing the return on the investment in health care programs
The Incorporation of Income and Leisure in Health State Valuations When the Measure Is Silent: An Empirical Inquiry into the Sound of Silence
Breaking the Silence: Exploring the Potential Effects of Explicit Instructions on Incorporating Income and Leisure in TTO Exercices
AbstractObjectivesAn underexplored question in the debate on incorporating productivity costs as costs or effects in a cost-effectiveness (CE) analysis is whether people include effects of ill health on income in health state valuations (HSV). The same holds for the actual inclusion in HSV of the effects of ill health on leisure. This study aims to test whether respondents to HSV using time trade-off (TTO) questions include income and leisure effects without instructions. Moreover, it tests the consequences of explicit instructions to include or exclude income effects.MethodsThree questionnaires were administered among the general public. Respondents were asked to value three distinct EuroQol descriptive system health states using TTO. In version 1, respondents were asked afterwards whether they included income effects. In versions 2 and 3, respondents were instructed upfront to include or exclude income effects. They were furthermore asked whether they included leisure effects.ResultsA total of 222 respondents completed the questionnaire. In version 1, 64% of the respondents spontaneously included income effects, not resulting in differences in mean valuations. In versions 2 and 3, 88% included leisure time, resulting in a significantly lower TTO value in one health state. With explicit instructions, respondents instructed to include income gave lower HSV for the worst health state presented.ConclusionsRespondents in our sample did not consistently include income effects and leisure effects. Including income effects only had (some) effect on TTO valuations after an explicit instruction. If these results are confirmed in future research, this implies that income effects may be best captured on the cost-side of the CE ratio. Spontaneous inclusion or exclusion of leisure time appeared to be more influential